March 12, 2026

Access Challenges for Septal Reduction Therapy Among Individuals With Obstructive Hypertrophic Cardiomyopathy.

Key Result

Most patients with obstructive hypertrophic cardiomyopathy received septal reduction therapy at standard centers instead of Centers of Excellence, despite traveling long distances.

Key Points

To examine the access challenges faced by patients with obstructive hypertrophic cardiomyopathy seeking septal reduction therapy.
Assessment of patient travel patterns to treatment centers.
Comparison between centers of excellence and standard treatment centers.
Analysis of patient demographics and treatment locations.
Most patients traveled long distances for septal reduction therapy.
A larger proportion of patients received therapy at standard centers instead of centers of excellence.

Structured PICO

Population

Individuals With Obstructive Hypertrophic Cardiomyopathy

Intervention

Septal Reduction Therapy (SRT)

Outcome

Access to Septal Reduction Therapy (travel distance and center type)

There are significant access challenges for septal reduction therapy in obstructive hypertrophic cardiomyopathy, with most patients receiving care at standard centers rather than high-volume Centers of Excellence.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Patients traveled long distances for SRT at COE/high-volume centers. Most patients received SRT at standard centers rather than at COE.